The publisher had three games in the quarter, but none hit estimates.

Got a news tip? Is there something you think we should be reporting on? Email news@usgamer.net.

Capcom announced its financial earnings report for the fiscal year ended on March 31, 2017, but the news wasn't amazing. Net sales and revenue were up for the company year-over-year, but more importantly, all of the publisher's major releases missed expectations.

Original estimates for the fiscal year saw Resident Evil 7 selling 4 million copies, alongside Monster Hunter XX and Dead Rising 4 with 2 million sold each. Instead, Resident Evil 7 came in around 3.5 million copies sold, Monster Hunter XX sold 1.7 million on 3DS, and Dead Rising 4 landed somewhere below 1 million units. For Resident Evil 7 and Monster Hunter XX, Capcom fell a bit short of expectations, but Dead Rising 4 was a major miss for the company.

"Resident Evil 7 biohazard gave an overall solid performance, while Monster Hunter XX is off to a promising start following its March 2017 release," said the company in its earnings release. "On the other hand, Dead Rising 4 and Monster Hunter Stories underperformed."

In addition, Street Fighter V only moved another 100,000 units during the quarter, with sales coming in at 1.6 million in total.

In the coming fiscal year, Capcom has Marvel vs. Capcom: Infinite, Ultra Street Fighter II: The Final Challengers, Great Ace Attorney 2, and additional Street Fighter V content planned for release. Hopefully, the company has a strong E3 with a host of new, exciting titles.